Cite
HARVARD Citation
Goldstone, S. et al. (2022). Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Lancet infectious diseases. 22 (3), pp. 413-425. [Online].